Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.9554
-0.0269-2.74%
Volume:142.93K
Turnover:136.89K
Market Cap:80.99M
PE:-0.38
High:0.9767
Open:0.9500
Low:0.9451
Close:0.9823
52wk High:4.80
52wk Low:0.5231
Shares:84.77M
Float Shares:67.15M
Volume Ratio:0.38
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5119
EPS(LYR):-2.9606
ROE:-347.64%
ROA:-27.54%
PB:-2.52
PE(LYR):-0.32

Loading ...

Sutro Biopharma Inc : Jefferies Cuts Target Price to $4 From $7

THOMSON REUTERS
·
Yesterday

Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

Sutro Biopharma Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Aug 09

Sutro Biopharma Q2 EPS $(0.14) Beats $(0.45) Estimate, Sales $63.74M Beat $14.35M Estimate

Benzinga
·
Aug 08

BRIEF-Sutro Biopharma Q2 Revenue USD 63.745 Million

Reuters
·
Aug 08

Sutro Biopharma Q2 Basic EPS USD -0.14

THOMSON REUTERS
·
Aug 08

Sutro Biopharma Inc - Reports $18.4 Mln in Restructuring Costs for Q2 2025

THOMSON REUTERS
·
Aug 08

Sutro Biopharma: Will Continue to Recognize Restructuring Costs for Deprioritization of Luvelta Program ,to Recognize a Significant Portion in 2025

THOMSON REUTERS
·
Aug 08

Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights

GlobeNewswire
·
Aug 08

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates

GlobeNewswire
·
Jul 22

Sutro Biopharma Inc. Faces Possible NASDAQ Delisting Over $1 Minimum Bid Price Non-Compliance

Reuters
·
Jun 26

Sutro Biopharma Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
Jun 17

Sutro Biopharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 11

Sutro Biopharma Appoints Greg Chow as New Chief Financial Officer, Effective June 2025

Reuters
·
Jun 02

Sutro Biopharma Is Maintained at Underperform by B of A Securities

Dow Jones
·
May 20

Sutro Biopharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
May 09

Sutro Biopharma Q1 EPS $(0.91) Misses $(0.71) Estimate, Sales $17.40M Beat $11.61M Estimate

Benzinga
·
May 09

BRIEF-Sutro Biopharma Q1 Revenue USD 17.399 Million

Reuters
·
May 09

Sutro Biopharma Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 29

Sutro Biopharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Mar 17